DXPE Stock UPDATES Dxp Enterprises (DXPE) 61.12 10/22/2014 0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dxp Enterprises (DXPE) 61.12 $DXPE

Shares of DXPE Down 23.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 20, 11:08AM CDT
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ XPE) on May 13th, 2014 at $77.20. In approximately 5 months, DXP Enterprises has returned 23.25% as of today's recent price of $59.24.
DXPE: 61.12 (+1.44)

Shares of DXPE Down 15.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 13, 10:28AM CDT
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ XPE) on May 13th, 2014 at $77.20. In approximately 5 months, DXP Enterprises has returned 15.76% as of today's recent price of $65.03.
DXPE: 61.12 (+1.44)

Xylem Wins Bahrain Contract, Outlook Solid on Order Backlog - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 11:10AM CDT
Xylem Inc. (XYL) recently has been awarded a $7.3 million contract by Bahrain's Ministry of Works. The contract win reflects the growing popularity of the company's world-class water and wastewater solutions.
IEX: 73.14 (+2.78), XYL: 34.51 (+0.80), MIDD: 85.71 (+3.10), DXPE: 61.12 (+1.44)

Twin Disc (TWIN) in Focus: Stock Falls 5.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 7:46AM CDT
Twin Disc Incorporated stock recorded a sharp fall of 5% in the last trading session
IEX: 73.14 (+2.78), MIDD: 85.71 (+3.10), TWIN: 24.45 (-0.35), DXPE: 61.12 (+1.44)

Nordson Buys Dima Group, Boosts Fluid Dispensing Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 10:50AM CDT
Nordson Corporation (NDSN) has acquired Dima Group B.V., a Netherland-based manufacturer of conformal coating, dispensing and surface mount technology (SMT) equipment, for an undisclosed amount. The transaction will have minimal impact on Nordson's results.
NDSN: 72.18 (+1.79), IEX: 73.14 (+2.78), MIDD: 85.71 (+3.10), DXPE: 61.12 (+1.44)

Caterpillar's (CAT) Cost Savings Surmount Mining Weakness - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 12:00PM CDT
On Aug 26, 2014, we issued an updated research report on Caterpillar Inc. (CAT), the mining and equipment behemoth.
IEX: 73.14 (+2.78), MIDD: 85.71 (+3.10), CAT: 95.89 (+1.86), DXPE: 61.12 (+1.44)

Dover (DOV) Shares Up as OPW Completes Acquisition of Liquip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 12:00PM CDT
Dover (DOV) has completed the acquisition of Liquip International.
IEX: 73.14 (+2.78), DOV: 76.64 (+2.05), DXPE: 61.12 (+1.44)

Chart Industries Downgraded to Strong Sell on Weak Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 11:10AM CDT
Zacks Investment Research downgraded Chart Industries Inc. (GTLS) to a Zacks Rank #5 (Strong Sell) on Aug 26, 2014. Going by the Zacks model, companies holding a Zacks Rank #5 have strong chances of performing worse than the broader market.
IEX: 73.14 (+2.78), GTLS: 47.99 (+2.02), DXPE: 61.12 (+1.44)

Caterpillar (CAT) July Sales down 9% Yet Graph Crawls Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 3:45PM CDT
Caterpillar Inc. (CAT) reported a 9% decline in its global retail sales for the three months ending Jul 2014.
IEX: 73.14 (+2.78), CAT: 95.89 (+1.86), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

Apogee Q2 to Benefit from Tax Credit & Architectural Market - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 2:50PM CDT
Apogee Enterprises, Inc. (APOG) announced its Q2 results will benefit from a tax credit of 20 cents per share.
IEX: 73.14 (+2.78), APOG: 40.83 (+1.10), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

Nordson Beats on Q3 Earnings, Higher Revenues Offset Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:00AM CDT
Nordson Corporation (NDSN) reported adjusted earnings of $1.20 per share for third-quarter fiscal 2014 (ended Jul 31, 2014). The bottom-line grew 21.2% year over year and surpassed the Zacks Consensus Estimate of $1.13 by 6.2%.
NDSN: 72.18 (+1.79), IEX: 73.14 (+2.78), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

What Falling Estimates & Price Mean for Manitex International (MNTX) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 7:36AM CDT
Manitex International is a stock to drop as it has witnessed negative trend in earnings estimate revisions and has seen its price decline significantly.
MNTX: 10.60 (+0.18), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

Nordson Corporation Hikes Quarterly Dividend, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 19, 10:40AM CDT
Nordson Corporation (NDSN) recently declared that its board of directors have approved a 22% increase in the quarterly dividend rate. This marks the 51st consecutive annual dividend increase for the company.
NDSN: 72.18 (+1.79), IEX: 73.14 (+2.78), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

Applied Industrial (AIT) Misses on Q4 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:20AM CDT
Applied Industrial Technologies missed the Zacks Consensus Estimate for earnings and revenues in fiscal fourth-quarter 2014.
IEX: 73.14 (+2.78), AIT: 46.34 (+1.28), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

Altra Industrial Downed to Strong Sell on Lowered Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 12:20PM CDT
Zacks Investment Research downgraded Altra Industrial Motion Corp. (AIMC) to a Zacks Rank #5 (Strong Sell) on Aug 13, 2014. Going by the Zacks model, companies holding a Zacks Rank #5 have strong chances of performing worse than the broader market.
DOV: 76.64 (+2.05), AIMC: 29.17 (+1.17), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

Dover (DOV) Acquires Liquip to Strengthen Fluids Segment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 5:00PM CDT
Dover (DOV) to acquire all the outstanding shares of Liquip International.
IEX: 73.14 (+2.78), IR: 58.34 (+1.19), DOV: 76.64 (+2.05), DXPE: 61.12 (+1.44)

Nordson Enters Medical Market with Avalon Laboratories Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 12:50PM CDT
Nordson Corporation (NDSN) acquires Avalon Laboratories for a total sum of $180 million.
NDSN: 72.18 (+1.79), IEX: 73.14 (+2.78), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

Illinois Tool Works Hikes Dividend 15%, Stock Gains 2% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 12:09PM CDT
Illinois Tool Works Inc. (ITW) announced a 15% increase in its quarterly dividend rate to 48.5 cents from 42 cents paid earlier. The company's share price gained 1.9%, closing the trading session at $84.60 on Aug 8.
IEX: 73.14 (+2.78), BLT: 14.90 (+0.46), ITW: 86.60 (+3.19), DXPE: 61.12 (+1.44)

Blount International Reaches 52-Week High on Strong Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 8:09AM CDT
Shares of Blount International (BLT), a machinery company, scaled a new 52-week high of $14.89 on Aug 8.
IEX: 73.14 (+2.78), TNC: 66.99 (+1.58), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)

Manitex Lags on Q2 Earnings, Shares Fall on Flat Y/Y Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 9:10AM CDT
Shares of Manitex International, Inc. (MNTX) slumped after reporting Q2 earnings of 22 cents, flat year over year, behind the Zacks Consensus Estimate.
IEX: 73.14 (+2.78), MNTX: 10.60 (+0.18), BLT: 14.90 (+0.46), DXPE: 61.12 (+1.44)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles